{"id":30420,"date":"2014-04-22T09:45:56","date_gmt":"2014-04-22T13:45:56","guid":{"rendered":"http:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/pfizer-treatment-for-psoriasis-shows-positive-results-in-studies\/"},"modified":"2014-04-22T09:45:56","modified_gmt":"2014-04-22T13:45:56","slug":"pfizer-treatment-for-psoriasis-shows-positive-results-in-studies","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/transhuman-news-blog\/psoriasis\/pfizer-treatment-for-psoriasis-shows-positive-results-in-studies\/","title":{"rendered":"Pfizer Treatment for Psoriasis Shows Positive Results in Studies"},"content":{"rendered":"

By Dow Jones Business News, April 22, 2014, 08:53:00 AM EDT <\/p>\n

By Tess Stynes <\/p>\n

Pfizer Inc. ( PFE ) said two Phase 3 studies to evaluate the effectiveness and safety of its treatment for adults with moderate-to-severe plaque psoriasis showed positive results. <\/p>\n

The studies of the twice-daily pill--known as tofacitinib -- at two dosing levels was more effective than a placebo in achieving a response of \"clear\" or \"almost clear\" at 16 weeks and in the portion of patients achieving at least a 75% reduction in the severity and area affected by psoriasis. <\/p>\n

Pfizer plans to submit a supplemental new drug application to the U.S. Food and Drug Administration by early next year. <\/p>\n

Tofacitinib -- sold domestically under the brand name Xeljanz -- is approved in more than 20 countries for adults with hard-to-treat cases of moderate-to-severe rheumatoid arthritis. <\/p>\n

Write to Tess Stynes at tess.stynes@wsj.com<\/a> <\/p>\n

Subscribe to WSJ: http:\/\/online.wsj.com?mod=djnwires<\/a> <\/p>\n

<\/p>\n

Excerpt from:
\nPfizer Treatment for Psoriasis Shows Positive Results in Studies<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

By Dow Jones Business News, April 22, 2014, 08:53:00 AM EDT By Tess Stynes Pfizer Inc. Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[22],"tags":[],"class_list":["post-30420","post","type-post","status-publish","format-standard","hentry","category-psoriasis"],"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts\/30420"}],"collection":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/comments?post=30420"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts\/30420\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/media?parent=30420"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/categories?post=30420"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/tags?post=30420"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}